Fact CheckerSign in

NCT04675476Active, not recruiting

A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening

A Multilevel Intervention to Address Health Disparities in Lung Cancer Screening

Source: ClinicalTrials.gov · Last updated 7 Oct 2026

Brief summary (registry, in English)

To test the impact of a multilevel intervention on primary (provider-patient communication, intentions, and knowledge) and secondary (screening referrals and completion) outcomes.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
368 (estimated)
First submitted
4 Dec 2020
Start date
11 Mar 2024
Primary completion date
31 Dec 2026
Lead sponsor
Georgetown University
Diseases
Lung cancer
NCT number
NCT04675476

What you commit to

  • Study type: Interventional
  • Planned participants: 368
  • From 11 Mar 2024 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Individuals with a history of lung cancer

Who the study is looking for

  • 50-80 years old;
  • current cigarette smoker or quit within 15 years;
  • a 20+ pack-year smoking history;
  • non-adherent to lung screening (\>13 months);
  • English-speaking;
  • scheduled for an upcoming clinic appointment (4 weeks - 8 weeks); and
  • able and willing to provide meaningful consent and complete telephone interviews

Age in the registry: 50 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
MedStar Health
Coordinator of this site? Confirm its status
Washington D.C.United StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.